Publications by authors named "Felix Lefort"

Claim this Profile
D
Diagnostic accuracy of [18F]-FDG-PET/CT for lymph node staging in bladder cancer prior to radical cystectomy.
Oscar Gouhizoun, Maxime Pattou, Fabienne Guéna, Abderrahmane Khaddad, Samy Mebroukine, Felix Lefort

World J Urol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary urethral cancer: Treatment patterns, responses and survival in localized, advanced and metastatic patients.
Ilfad Blazevic, Aude Fléchon, Géraldine Pignot, Benoît Mesnard, Jérôme Rigaud, Felix Lefort

BJUI Compass· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of lenvatinib-based therapy in previously treated patients with metastatic renal cell carcinoma: A European multicenter study (LENVA-LAT).
Javier Gavira, Edouard Auclin, Macarena Rey-Cardenas, Pritha Roy, Jose C Tapia, Felix Lefort

Eur J Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resolution of immune checkpoint inhibitors-induced inflammatory arthritis while maintaining active treatment with checkpoint inhibitors and after its discontinuation: An observational study.
Alexandra Ladouceur, Thomas Barnetche, Sorilla Prey, Caroline Dutriaux, Émilie Gerard, Felix Lefort

Joint Bone Spine· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concomitant chemotherapy in trimodal treatment of patients with muscle invasive bladder cancer: A systematic review of prospective trials.
Camille Baudelin, Paul Sargos, Derek Dinart, Christophe Hennequin, Diego Teyssonneau, Félix Lefort

Crit Rev Oncol Hematol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival following anti-PD-(L)1 monotherapy in advanced urothelial cancer and an assessment of potential prognostic clinical factors: a multicentre observational study.
Chantal F Stockem, Sarah M H Einerhand, Isabel Miras Rodríguez, Youssra Salhi, Esther Pérez, Felix Lefort

BJC Rep· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FGF amplification an important targeted for head and neck cancer patient? A case report of a patient with FGF amplification treated with erdafitinib.
Nyere Gibson, Mathieu Larroquette, Charlotte Domblides, Felix Lefort, Amaury Daste

Eur J Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How Immunotherapy Has Redefined the Treatment Paradigm of Metastatic or Locally Advanced Muscle-Invasive Urothelial Bladder Carcinoma.
Mathieu Larroquette, Félix Lefort, Charlotte Domblides, Luc Héraudet, Grégoire Robert

Cancers (Basel)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human NLRC4 expression promotes cancer survival and associates with type I interferon signaling and immune infiltration.
Charlotte Domblides, Steven Crampton, Hong Liu, Juliet M Bartleson, Annie Nguyen, Félix Lefort

J Clin Invest· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive analyses of immune tumor microenvironment in papillary renal cell carcinoma.
Manon de Vries-Brilland, Nathalie Rioux-Leclercq, Maxime Meylan, Jonathan Dauvé, Christophe Passot, Félix Lefort

J Immunother Cancer· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint inhibitor rechallenge in patients who previously experienced immune-related inflammatory arthritis: a multicentre observational study.
Alexandra Ladouceur, Thomas Barnetche, Gael Mouterde, Alice Tison, Samuel Bitoun, Felix Lefort

RMD Open· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Biological Differences between Upper Tract Carcinoma and Bladder Urothelial Cancer, Including Implications for Clinical Practice.
Félix Lefort, Yasmine Rhanine, Mathieu Larroquette, Charlotte Domblides, Luc Heraudet

Cancers (Basel)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Corticosteroids With Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With Nivolumab.
Félix Lefort, Cécile Dalban, Marine Gross-Goupil, Brigitte Laguerre, Sylvie Chabaud

JAMA Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combinations of Anti-Angiogenic Agents and Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Best Option?
Estelle Granet-Vaissiere, Félix Lefort, Charlotte Domblides, Mathieu Larroquette, Alain Ravaud

Cancers (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Management of Metastatic Clear Cell Renal Cell Carcinoma: A Revolution in Every Decade.
Mathieu Larroquette, Félix Lefort, Luc Heraudet, Jean-Christophe Bernhard, Alain Ravaud

Cancers (Basel)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy following immune checkpoint inhibitors in patients with locally advanced or metastatic urothelial carcinoma.
Lucie Meynard, Derek Dinart, Blandine Delaunay, Aude Fléchon, Carolina Saldana, Félix Lefort

Eur J Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of FDG- PET CT in the Management of Muscle Invasive Bladder Cancer.
Pauline Bertolaso, Véronique Brouste, Anne-Laure Cazeau, Henri de Clermont-Gallerande, Franck Bladou, Felix Lefort

Clin Genitourin Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Evaluation of Cabozantinib for the Treatment of Renal Cell Carcinoma: Focus on Patient Selection and Perspectives.
Romain Iaxx, Felix Lefort, Charlotte Domblides, Alain Ravaud, Jean-Christophe Bernhard

Ther Clin Risk Manag· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic renal cell cancer and first-line combinations: for which patients? (focus on tolerance and health-related quality of life).
Antoine El Kaddissi, Guillemette Guilhem Ducleon, Félix Lefort, Garvey Mezepo, Alexandre Frontczak

Bull Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thyroid-like follicular renal cell carcinoma with sarcomatoid differentiation and an aggressive clinical course: a case report confirming the presence of the EWSR1::PATZ1 fusion gene.
Raul Perret, Felix Lefort, Jean-Christophe Bernhard, Jessica Baud, François Le Loarer

Histopathology· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
REchallenge of NIVOlumab (RENIVO) or Nivolumab-Ipilimumab in Metastatic Renal Cell Carcinoma: An Ambispective Multicenter Study.
Charles Vauchier, Edouard Auclin, Philippe Barthélémy, Lucia Carril-Ajuria, Thomas Ryckewaert, Felix Lefort

J Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Everolimus or sunitinib as first-line treatment of metastatic papillary renal cell carcinoma: A retrospective study of the GETUG group (Groupe d'Etude des Tumeurs Uro-Génitales).
Mathilde Cancel, Gaelle Fromont, Cyriac Blonz, Christine Chevreau, Nathalie Rioux-Leclercq, Félix Lefort

Eur J Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining immune checkpoint inhibitors with chemotherapy in advanced solid tumours: A review.
Mathieu Larroquette, Charlotte Domblides, Félix Lefort, Matthieu Lasserre, Amandine Quivy

Eur J Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant therapy in renal cell carcinoma: Current knowledges and future perspectives.
Mathieu Larroquette, Florent Peyraud, Charlotte Domblides, Félix Lefort, Jean-Christophe Bernhard

Cancer Treat Rev· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Role of Inflammasome Components in Human Colorectal Cancer.
Charlotte Domblides, Isabelle Soubeyran, Lydia Lartigue, Isabelle Mahouche, Félix Lefort

Cancers (Basel)· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis